Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Nippon Shokubai

Corporate venture profile

Parent Nippon Shokubai

This profile covers the startup investments made by Nippon Shokubai, a chemicals and materials company. It invests at the Series A stage. Sectors it names: biotech and life sciences, climate and energy.

Every figure links to its source

Snapshot

Investment stage: Series A to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series A
SectorsBiotech and life sciences, Climate and energy
GeographyAsia

Sources: S2 PR TIMES: capital alliance of PURMX Therapeutics with Nippon Shokubai.

Graphic 1 of 1

Investment stage: Series A to Series A

Sources: S2 PR TIMES: capital alliance of PURMX Therapeutics with Nippon Shokubai.

Download:Report a correction

Where it invests

Geography

Investment regionsS2

Key facts

FactValueStatusSource
Parent companyNippon ShokubaiSingle sourceS1
Parent industryChemicals and materialsSingle sourceS1
Capital sourceParent company onlySingle sourceS1
StagesSeries A (inferred from announced rounds)EstimateS2

History

  1. Initial investment; stake raised to 35.28 percent by 2019 allotmentS1
  2. Capital alliance and joint research on Fol-Dab8 microRNA complexS2

Portfolio

Portfolio companies named in public sources: TAK-Circulator, PURMX Therapeutics.S1

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Nippon Shokubai release: business alliance and third-party allotment in TAK-Circulator (2022)Firm
  2. S2PR TIMES: capital alliance of PURMX Therapeutics with Nippon ShokubaiPress
  3. S3FIRST CVC: Nippon Shokubai startup investment and collaborationThird-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Nippon Shokubai or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.